Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Labs’ Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, July 16, 2012 - 7:31pm
tags:
earnings, Abbott Laboratories
Antitrust regulators tell Novartis to sell 4 skin care products as part of $1.5B Fougera deal
Yahoo/AP
Monday, July 16, 2012 - 7:31pm
tags:
FTC, Novartis, Fougera
Vivus, Orexigen climb ahead of FDA decision
Marketwatch
Monday, July 16, 2012 - 2:02pm
tags:
Orexigen, FDA, obesity, Vivus, Qnexa, Contrave
Gilead Wins U.S. Approval For First HIV Prevention Pill
Bloomberg
Monday, July 16, 2012 - 1:41pm
tags:
Gilead, HIV, AIDS, Truvada
Alabama Court Tosses Verdict Against Sandoz
Pharmalot
Monday, July 16, 2012 - 12:26pm
tags:
Alabama, Sandoz, Novartis, Medicaid fraud
GSK and Theravance file next-generation Advair in USA, EU
Pharma Times, UK
Monday, July 16, 2012 - 12:24pm
tags:
Advair, GSK, Theravance, Breo, COPD, asthma
Par Pharmaceutical agrees to be acquired by TPG affiliate for about $1.84 billion in cash
Washington Post, DC
Monday, July 16, 2012 - 12:22pm
tags:
M&A, Par Pharmaceutical
Alnylam soars 31% on drug study
Marketwatch
Monday, July 16, 2012 - 12:21pm
tags:
Alnylam, ALN-TTR02, TTR-mediated amyloidosis
Forest Labs asks shareholders to reject Icahn slate
Reuters
Monday, July 16, 2012 - 12:17pm
tags:
Carl Ican, Forest Labs
Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com
Monday, July 16, 2012 - 12:16pm
tags:
Eli Lilly, Verastem, Celgene, QLT, Amylin
2 Highly Attractive Pharmaceutical Companies Set To Soar
Seeking Alpha
Monday, July 16, 2012 - 12:14pm
tags:
Vivus, Pfizer, Arena Pharmaceuticals, Amylin, Abbott Laboratories
1 Reason WuXi PharmaTech's Earnings Aren't So Hot
Motley Fool
Monday, July 16, 2012 - 12:11pm
tags:
WuXi PharmaTech, earnings
Sanofi Pasteur begins shipping Fluzone influenza virus vaccine in the U.S.
Yahoo/Fly on the Wall
Monday, July 16, 2012 - 12:04pm
tags:
Sanofi Pasteur, vaccines, flu vaccine, Fluzone
4 Reasons To Buy Anthera Pharmaceuticals
Seeking Alpha
Monday, July 16, 2012 - 12:04pm
tags:
Anthera
Human Genome agrees to Glaxo's $3.6B bid
Marketwatch
Monday, July 16, 2012 - 11:54am
tags:
GSK, M&A, Human Genome Sciences
Johnson & Johnson Reports July 17th - Is A Turnaround In The Offing?
Seeking Alpha
Monday, July 16, 2012 - 8:50am
tags:
JNJ, earnings
Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Bloomberg
Monday, July 16, 2012 - 8:48am
tags:
prostate cancer, Medivation, M&A, AbbVie, Astellas, Enzalutamide
Sanofi: Don't Ignore This Powerhouse
Seeking Alpha
Monday, July 16, 2012 - 8:47am
tags:
Sanofi, Merck, Pfizer, Bristol-Myers Squibb, Bayer
Partnership and Acquisition in the Red Hot Weight Loss Market
Motley Fool
Monday, July 16, 2012 - 8:45am
tags:
Vivus, Arena Pharmaceuticals, obesity, M&A, Qnexa, Belviq, Pfizer, JNJ, Eisai
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Seeking Alpha
Sunday, July 15, 2012 - 12:25pm
tags:
Fusilev, Spectrum Pharmaceuticals, colorectal cancer, colon cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.